Cite
Post-translational modification of CDK1–STAT3 signaling by fisetin suppresses pancreatic cancer stem cell properties.
MLA
Xu, Xiaodong, et al. “Post-Translational Modification of CDK1–STAT3 Signaling by Fisetin Suppresses Pancreatic Cancer Stem Cell Properties.” Cell & Bioscience, vol. 13, no. 1, Sept. 2023, pp. 1–21. EBSCOhost, https://doi.org/10.1186/s13578-023-01118-z.
APA
Xu, X., Ding, Y., Jin, J., Xu, C., Hu, W., Wu, S., Ding, G., Cheng, R., Cao, L., & Jia, S. (2023). Post-translational modification of CDK1–STAT3 signaling by fisetin suppresses pancreatic cancer stem cell properties. Cell & Bioscience, 13(1), 1–21. https://doi.org/10.1186/s13578-023-01118-z
Chicago
Xu, Xiaodong, Yimin Ding, Junbin Jin, Chengjie Xu, Wenyi Hu, Songtao Wu, Guoping Ding, Rui Cheng, Liping Cao, and Shengnan Jia. 2023. “Post-Translational Modification of CDK1–STAT3 Signaling by Fisetin Suppresses Pancreatic Cancer Stem Cell Properties.” Cell & Bioscience 13 (1): 1–21. doi:10.1186/s13578-023-01118-z.